DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /Metabolic EnzymesMetabolic Enzymes
  5. /CathepsinCathepsin
  6. /PetesicatibPetesicatib
Chemical structure of CAS 1252637-35-6

Petesicatib

In Stock•Starting at $470 for 1 mg•Purity ≥ 98%
CAS No.1252637-35-6
MDL No.N/A
MFC25H23F6N5O4S
MW603.50
InChI KeyKXAAIORSMACJSI-AEFFLSMTSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg98%$470In Stock
5 mg98%$970In Stock
10 mg98%$1802In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1252637-35-6
Product NamePetesicatib
Heavy Atom Count41Rotatable Bond Count6
Atom Stereo Count2Bond Stereo Count0
HBA7HBD1
TPSA125.160 ŲCharge0
Exact Mass603.13749Complexity1567.61
pKa9.613XLogP3.364

Related Articles

Studies related to this compound and its mechanism of action

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020
PMID: 32020584PMC: PMC7160657DOI: 10.1111/imm.13175

Pharmacodynamic Monitoring of RO5459072, a Small Molecule Inhibitor of Cathepsin S.

Frontiers in immunology • Vol. 8 • 2017
PMID: 28769925PMC: PMC5512459DOI: 10.3389/fimmu.2017.00806

Cathepsin S inhibition combines control of systemic and peripheral pathomechanisms of autoimmune tissue injury.

Scientific reports • Vol. 7, Issue 1 • 2017
PMID: 28584258PMC: PMC5459853DOI: 10.1038/s41598-017-01894-y

Documentation

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact